IFNA2, interferon alpha 2, 3440

N. diseases: 355; N. variants: 1
Source: ALL
Disease Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
CUI: C0023530
Disease: Leukopenia
Leukopenia
0.310 Biomarker disease BEFREE A population pharmacodynamic model characterizing neutropenia associated with pegylated interferon alpha 2-a therapy in patients with chronic hepatitis C viral infection. 29872876 2018
CUI: C0023530
Disease: Leukopenia
Leukopenia
0.310 Biomarker disease CTD_human A randomized study comparing interferon (IFN alpha) plus low-dose cytarabine and interferon plus hydroxyurea (HU) in early chronic-phase chronic myeloid leukemia (CML). 12620292 2003
CUI: C0023530
Disease: Leukopenia
Leukopenia
0.310 Biomarker disease CTD_human Efficacy and toxicity of IFN-alpha2b combined with cytarabine in chronic myelogenous leukaemia. 10520005 1999
CUI: C0023530
Disease: Leukopenia
Leukopenia
0.310 Biomarker disease CTD_human [Combination therapy with 5-fluorouracil (5-FU), cisplatin (CDDP) and interferon alpha-2B (IFN alpha-2B) for advanced renal cell carcinoma]. 8886046 1996
CUI: C0023530
Disease: Leukopenia
Leukopenia
0.310 Biomarker disease CTD_human Combination trial of subcutaneous interferon alfa-2b and oral cyclophosphamide in favorable histology, non-Hodgkin's lymphoma. 3298131 1987
CUI: C0023530
Disease: Leukopenia
Leukopenia
0.310 Biomarker disease CTD_human Interferon alfa-2b/melphalan/prednisone in previously untreated patients with multiple myeloma: a phase I-II trial. 3597002 1987